Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

New Product Launch

4 Aug 2005 07:00

Plant Health Care PLC04 August 2005 Embargoed until 7am 4 August 2005 Plant Health Care plc Plant Health Care and Symbiot Business Group Enter into Exclusive Agreement Plant Health Care plc ("PHC" or the "Company"), the leading supplier of naturalproducts for plants and soil, announces it has entered into a strategic,exclusive partnership with US-based Symbiot Business Group (SBG). Under the agreement, PHC becomes a Premier Business Partner to Symbiot's networkof top-tier, independent landscape contractors from across the U.S. PHC will bethe exclusive supplier of natural and biologically-based products to the entirePartner network consisting of over 500 landscape contractors. John Brady, CEO of PHC commented, "We are very excited to be able to offer theSymbiot Landscape Network advanced training and marketing support to help themeffectively promote Plant Health Care products to their customers. Participatingin Symbiot's Business Partners programme gives PHC the opportunity to workclosely with one of the most respected landscape companies in the business. "We believe that this is another strong indication that PHC's business strategyis working well and offers further validation of our technology and products.The benefits of this arrangement will become apparent in 2006 and thereafter aswe begin to derive revenues from Symbiot's business partners." PHC and Symbiot Business Group will work closely to develop joint marketingprogrammes and promote PHC product sales through other Symbiot BusinessPartners. For further information please contact: Plant Health Care plc Tavistock CommunicationsJohn Brady, CEO Christian Taylor-WilkinsonTel: 001 603 525 3702 Tel: 020 7920 3150 email: ctaylor-wilkinson@tavistock.co.uk Notes to Editors: About Plant Health Care - Plant Health Care plc ("PHC") is a leading provider ofnatural products for plants and soil. Established in 1995 in Pittsburgh(Pennsylvania) in the United States, PHC currently has approximately 60employees and has operations in the US, Mexico, UK, Spain, and the Netherlandswith technical support in Austria. The Group has two principal operatingsubsidiaries in the US - PHC Inc (PA) and PHC-REC. The Company listed on the AIMmarket of the London Stock Exchange in July 2004. PHC's products are aimed at the horticulture, agriculture, turf grass,commercial landscaping, forestry and land reclamation industries and are bothenvironmentally beneficial and on the whole more cost effective than syntheticchemical alternatives. Through the commercialisation of these products, PHC iscapitalising on current long-term trends toward natural systems and biologicalproducts for plant care and soil and water management uses. PHC-REC is an environmental and reclamation engineering consulting firm whichprovides engineering and design services for reclamation lands disturbed bymining, construction, and other activities. PHC-REC is the recognised leader inthe use of biologically based solutions using mycorrhizal fungi and bacteria forthe establishment of trees, shrubs, and grasses on these disturbed lands.PHC-REC was established in 1997 to exploit PHC's products and technology. For more information about PHC, visit http://www.healthplantcare.com About Symbiot Business Group - Symbiot Business Group benefits national andmulti-regional asset managers by reducing their total cost of contractedproperty services. Symbiot accomplishes this by delivering the efficiencies ofmultiple property services with national reach and pricing. The delivery methodof these efficiencies is unique in the marketplace, as Symbiot recruits top-tierregional players to provide consistent, superior services. To date, Symbiot hassuccessfully developed consortiums in the landscaping, interior, snow and pestindustries that currently represent nearly 1,000 partner companies and acombined annual buying strength of more than $1.5 billion. The phenomenal uptakeof the Symbiot model is due to the credibility of the Symbiot management team inits target verticals and the value Symbiot delivers to partners. For more information about Symbiot, visit http://www.symbiot.biz or call +1(866) 223-9049. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
27th Jan 20214:41 pmRNSSecond Price Monitoring Extn
27th Jan 20214:36 pmRNSPrice Monitoring Extension
25th Jan 20217:00 amRNSTrading Statement
11th Jan 20217:00 amRNSNotice of Trading Statement/Investor Presentation
5th Jan 20213:37 pmRNSBrazil approves PHC279 to Control Soybean Rust
11th Dec 20207:00 amRNSInvestor Presentation
9th Nov 20207:00 amRNSPlant Health Care and Wilbur-Ellis sign Agreement
7th Oct 20207:00 amRNSGrant of Options
6th Oct 20207:00 amRNSNew US PREtec Patents Issued
2nd Oct 20205:48 pmRNSSignificant Shareholder
25th Sep 20207:00 amRNSInvestor Presentation
23rd Sep 20207:00 amRNSInvestor Presentation
15th Sep 20207:00 amRNSInterim Report 30 June 2020
29th Jul 20207:00 amRNSTrading Statement
26th Jun 20204:41 pmRNSSecond Price Monitoring Extn
26th Jun 20204:36 pmRNSPrice Monitoring Extension
25th Jun 20207:00 amRNSGrant of Options
18th Jun 20204:41 pmRNSSecond Price Monitoring Extn
18th Jun 20204:36 pmRNSPrice Monitoring Extension
16th Jun 20207:00 amRNSPHC398 Approved by US EPA: PHC279 submitted to EPA
9th Jun 20207:00 amRNSGrant of options
2nd Jun 202011:13 amRNSResult of AGM
29th May 20207:00 amRNSHolding(s) in Company
27th May 20207:00 amRNSUpdate on PHC279 2019 Field Trials
6th May 20205:12 pmRNSAnnual Report & Accounts and AGM Notice Published
1st May 20203:21 pmRNSDirector/PDMR Shareholding
24th Apr 20207:00 amRNSResults for the year ended 31 December 2019
25th Mar 20207:00 amRNSHolding(s) in Company
23rd Mar 20203:45 pmRNSHolding(s) in Company
19th Mar 20203:09 pmRNSHolding(s) in Company
16th Mar 202011:53 amRNSResults of General Meeting
11th Mar 20207:00 amRNSPHC279 Submitted for Regulatory Approval in Brazil
24th Feb 20209:18 amRNSResults of Placing and Subscription
24th Feb 20207:00 amRNSProposed Placing and Subscription
19th Feb 20207:00 amRNSBlock listing Interim Review
5th Feb 20207:00 amRNSEmploy California Registration
23rd Jan 20207:00 amRNSFirst US patent issues for PREtec peptide products
9th Jan 20207:00 amRNSBrazil Update
20th Dec 20197:00 amRNSHolding(s) in Company
19th Dec 20197:00 amRNSTrading Update
3rd Dec 20196:35 pmRNSHolding(s) in Company
22nd Nov 20192:11 pmRNSHolding(s) in Company
15th Nov 20193:42 pmRNSHolding(s) in Company
15th Nov 20193:36 pmRNSHolding(s) in Company
14th Nov 20193:36 pmRNSHolding(s) in Company
14th Nov 20197:00 amRNSHolding(s) in Company
13th Nov 20194:40 pmRNSHolding(s) in Company
13th Nov 20194:08 pmRNSHolding(s) in Company
13th Nov 20193:59 pmRNSHolding(s) in Company
13th Nov 20193:42 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.